A study on design & development of betamethasone acetate and betamethasone sodium phosphate extended-release suspension
Background: The development of an injectable composition of betamethasone sodium phosphate and betamethasone acetate with an equivalent drug release profile to the marketed reference drug product, "Celestone Soluspan®," is highly challenging. To overcome this drug development problem, ther...
Saved in:
| Main Authors: | Amit Bansal, Satish Sardana, Tarun Wadhwa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Creative Pharma Assent
2025-06-01
|
| Series: | Journal of Applied Pharmaceutical Research |
| Subjects: | |
| Online Access: | https://japtronline.com/index.php/joapr/article/view/922 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Betamethasone latency period and neonatal hypoglycemia in term infants
by: Lauren A. Buckley, et al.
Published: (2025-12-01) -
Cushing’s syndrome in a young woman due to prolonged betamethasone nasal drop use: a case report
by: Mohammadsadra Shamohammadi, et al.
Published: (2025-07-01) -
EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION
by: A. A. Ryabtseva, et al.
Published: (2016-09-01) -
Best Responders and Super-Responders to Calcipotriol and Betamethasone Dipropionate PAD-Cream: A Post Hoc Pooled Analysis of Two Phase 3 Trials
by: Andreas Pinter, et al.
Published: (2025-04-01) -
Pharmaceutical development specifics of new generic drug products in suspension for injection form on the Betaspan depot (Depos) example
by: O. I. Kachaput, et al.
Published: (2017-08-01)